News

What Is HBOT Actually Approved For? UHMS Indications and FDA-Cleared Uses

The recognized indication lists from UHMS and the FDA are shorter than most marketing pages suggest. Here is what each body actually covers, and where the two overlap.

What Actually Happens During a Professional HBOT Session

Assessment, pressurization, ear equalization, session length and how many treatments to expect - a step-by-step look at a clinical HBOT session based on major medical centers.

HBOT for Diabetic Foot Ulcers: What the Cochrane Review Actually Found

A Cochrane review found a short-term healing signal for diabetic foot ulcers but no lasting benefit and no reduction in amputations. Here is the honest reading of the evidence.

HBOT for Late Radiation Tissue Injury: What the Cochrane Review Shows

For radiation proctitis and some head and neck tissue, a Cochrane review found HBOT may help. For other tissues the evidence is thin. An honest look at late radiation injury.

Carbon Monoxide Poisoning: The Weaver Trial and Why CO Is a Core HBOT Indication

A landmark 2002 NEJM trial reported fewer cognitive problems after HBOT for acute carbon monoxide poisoning. The wider evidence is mixed, but CO remains a core emergency indication.

Sudden Hearing Loss: What the AAO-HNS 2019 Guideline Says About HBOT

The 2019 AAO-HNS guideline lists HBOT with steroids as an option for sudden sensorineural hearing loss, but only within specific time windows and as a may-offer recommendation.

Decompression Sickness: Why Recompression Is the Definitive Treatment

For decompression sickness, recompression with oxygen in a hyperbaric chamber is the definitive treatment. DAN guidance and why chamber networks matter for divers.

HBOT and Stroke Recovery: What the Efrati 2013 Trial Did and Did Not Show

A 2013 trial reported neurological gains from HBOT in chronic stroke patients. It is an intriguing signal, but major guidelines have not adopted HBOT for stroke. An honest read.

HBOT for Sports Injury Recovery: What the Evidence Does and Does Not Show

Small studies hint at faster recovery from some sports injuries, but the evidence is developing and mixed. A buyer-honest look at HBOT and return to play.

The HBOT and Telomere Study: What the 2020 Aging Paper Actually Reported

A 2020 trial reported longer telomeres and fewer senescent cells after 60 HBOT sessions. The findings are striking but hypothesis-generating, not proof of slower aging.

HBOT and Fibromyalgia: Promising Trials That Still Need Replication

Israeli randomized trials report symptom relief and brain-imaging changes in fibromyalgia, especially after trauma. The results are encouraging but single-center and small.

Fire Safety in Hyperbaric Facilities: What NFPA 99 and the FDA Expect

Oxygen-rich chambers carry a real fire risk. NFPA 99 Chapter 14 and a 2025 FDA safety letter set out grounding, materials and training rules operators must follow.

Why Elite Athletes Are Adopting HBOT - and Why That Is Not Proof It Works

From the NBA to Olympic pools, HBOT is spreading through elite sport as a recovery tool. Adoption is a market signal, not evidence that the therapy works.

The HBOT Device Market in 2025: Growth Forecasts and the Wellness Surge

Analysts value the HBOT device market in the billions and forecast steady growth, driven partly by wellness and mild-chamber demand. The figures are estimates, not certainties.

HBOT for migraine and cluster headache: what the evidence actually shows

Weak, low-quality evidence suggests hyperbaric oxygen may ease some acute migraines but not prevent them. For cluster headache, ordinary high-flow oxygen has the stronger case.

FDA Reminds Providers to Follow Safe-Use Instructions for HBOT Devices

After reports of fires, injuries and deaths, the FDA's August 2025 letter urges providers to follow HBOT device safe-use instructions - and it matters for buyers too.

HBOT and Long COVID: What a 2025 Patient Registry Adds, and What It Cannot

A prospective registry of 232 long-COVID patients reports quality-of-life gains after 40 HBOT sessions. Why registries inform, but cannot replace, controlled trials.

A Sham-Controlled Trial of HBOT for Veterans With Combat-Related PTSD

A randomized, sham-controlled trial in male veterans reports reductions in PTSD and depression scores after HBOT. How the sham design works, and where the limits lie.

Double-Blind Trial: HBOT for Persistent Symptoms After Brain Injury

A double-blind trial gave 40 HBOT or sham sessions to adults with lasting symptoms after brain injury. The oxygen group improved on the primary measure, with caveats.

HBOT for Muscle Recovery: What the 2025 Evidence Actually Shows

A 2025 meta-analysis links HBOT to faster recovery from muscle injury, while Cochrane found no clear benefit for soreness. What recovery-chamber buyers can honestly expect.

Phillies Sign Multi-Year Mobile HBOT Deal: A Market Signal, Read Carefully

The Philadelphia Phillies say they are the first MLB team to invest in a mobile HBOT platform. What professional-sport adoption does, and does not, tell buyers.

The Safety Profile of HBOT: What a Meta-Analysis of Adverse Effects Shows

A meta-analysis of 24 trials finds HBOT's most common adverse effect is ear barotrauma, with serious events rare. Why supervised operation and screening still matter.

HBOT for Ulcerative Colitis: Early Trials and an Ongoing UCLA Study

Small trials suggest HBOT may help hospitalized ulcerative-colitis flares, and a larger UCLA trial is underway. Strictly experimental, and only as an adjunct.

HBOT Benefits

HBOT Benefits, Discover the top HBOT benefits and how Hyperbaric Oxygen Therapy can accelerate healing, improve brain health, and boost wellness - naturally...

Hyperbaric Oxygen Therapy (HBOT) and Its Impact on Physical Performance: A Scientific Perspective

Bryan Johnson - Longevity Expert